Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
about
The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivatorInteraction of the HPV E7 proteins with the pCAF acetyltransferaseHuman herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsEpstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchICIdentification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activityNuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complexHistone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREBInhibition of p300/CBP by early B-cell factorInterferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuitCoactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activatorChromatin organization in pluripotent cells: emerging approaches to study and disrupt functionHost epigenetic modifications by oncogenic virusesStructural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHEpigenetic Impact on EBV Associated B-Cell LymphomagenesisProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alphaMolecular virology of Kaposi's sarcoma-associated herpesvirusInteraction between the HPV E7 oncoprotein and the transcriptional coactivator p300Adenovirus E1A requires the yeast SAGA histone acetyltransferase complex and associates with SAGA components Gcn5 and Tra1.BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.Binding of p300/CBP co-activators by polyoma large T antigen.Functional interaction between p/CAF and human papillomavirus E2 protein.Role of chromatin during herpesvirus infections.Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infectionEpigenetic regulation of EBV persistence and oncogenesis.Chromatin organization of gammaherpesvirus latent genomes.Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.EBNA-LP associates with cellular proteins including DNA-PK and HA95.Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-associationEpstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growthC-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cellsRNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosisMolecular virology of Epstein-Barr virus.
P2860
Q22330805-27661E4D-F974-42D4-AA31-44CE78C0AC50Q24305508-8033327D-F6D4-47FF-94EA-54FB2B0B6C47Q24527215-671EC51D-5E0D-407D-B103-8693ED9FDA7EQ24530175-12FD0209-1783-4308-A3A8-556EF98E6D99Q24534465-E4D9E83F-84A1-43C0-BC36-8DC46FCC7BCCQ24537547-16EB0186-38DD-40C4-94E6-FD9C83F72927Q24540313-2909A628-BA0A-4744-A595-7A0D2DA5E337Q24540435-CF77762A-9174-4513-8C5C-31EF8B273594Q24550850-408FDD2C-81CD-465C-9A98-9E1FABEAFEC2Q24553129-06384CF0-D2F9-4615-B4E9-9736DD8BDFBFQ24673236-95D8E661-F007-41B6-98DB-4CC0B8C880FEQ24683031-F4F11AB8-2D35-4FDE-B451-7A8D27499B6DQ24791567-D156ECB8-086B-4FAD-AE19-616FE562CA5CQ26800018-84B8F638-BCD0-4354-8609-B96448B0C1B9Q27485909-97855A34-B00B-4DE2-8562-05D3287D2B78Q27682610-DEEA599B-4833-4251-B82B-DD194DA9C25CQ28068361-D0951F03-DE8D-4AFB-820A-93BEBF96145CQ28114910-5107DD9D-6198-4788-9BD6-E2162D801FDDQ28117643-554EEAEE-94BB-44BF-ABA0-833D360A2EF6Q28363323-3C16D33D-773D-47A3-9F31-90202BCFD1D1Q28566098-FA14DBDD-B6E3-4AD0-9F62-6CAF0B5685A5Q30308769-B4E66733-F105-46C9-AB30-27B499834CB0Q30981859-CAA8846E-BB24-48D1-906C-849BF3A57BDBQ33209208-17EA6A2E-1F37-4854-8BCE-871BE8E17A92Q33289405-BF52879C-E450-4271-B2B3-524F6EB28223Q33292254-21FD440A-1B2D-4912-B7F7-FD58EEA5B1E8Q33346968-1719076A-60B9-471D-AA06-1D4AC5CCBB5FQ33604108-06DF321F-5528-4CFC-B9BC-1B85CF87B2A6Q33658144-AF45CCFA-F15B-48BD-AE93-BC88E4D72240Q33723664-A70CD6A0-F99D-4938-81E1-8CFAB2F3E668Q33729584-A5D02C6D-F91F-40A8-BEC1-619DB30F5681Q33842309-DDD0AC29-261E-40A6-B886-34FE4EE71A41Q33850943-AB870938-8486-472A-9A52-2B3FA9606607Q33850964-264DCCA5-1475-4EF1-9678-4D2813E88C0BQ33953070-A5E818DB-311A-4262-AC5C-1C4E1DFE742BQ33998709-2DAD0DDC-C3E0-4138-B569-8C9C96971875Q34034925-AD60E951-211D-4ADB-9AFD-B69E60A44891Q34064221-14AA41D4-CF01-49E1-A051-3E5A7FDE4BF0Q34154616-97F9A172-B36B-44DB-A60F-F716F76E9E22Q34225554-0E8A7128-9898-4339-ACA1-7A37F85109B7
P2860
Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@en
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@nl
type
label
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@en
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@nl
prefLabel
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@en
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@nl
P2860
P356
P1476
Epstein-Barr virus nuclear pro ...... tivation of the LMP1 promoter.
@en
P2093
P2860
P304
P356
10.1073/PNAS.97.1.430
P407
P577
2000-01-01T00:00:00Z